Lung Cancer News

Most people at high risk for lung cancer have not discussed screening for the disease with their clinician or have even heard of the test, according to a research letter published in JAMA Network Open.

In this edition, single-fraction SBRT outcomes for central lung tumors, adjuvant durvalumab extends survival in limited-stage small cell lung cancer and more.

In this special crossover episode of Oncology Overdrive, we bring you Healio coverage from the 2024 World Conference on Lung Cancer, as well as Healio’s top headlines from the meeting.

Cancer diagnoses fell significantly below expectations in 2020 due to the COVID-19 pandemic but recovered to projected levels the following year, according to results of a cross-sectional study.

Researchers developed a highly sensitive, analytic, quantitative immunofluorescence assay that may enable more patients with lung cancer to benefit from an approved targeted therapy.

Single-fraction stereotactic body radiation therapy may be an effective treatment for individuals with central lung cancer, according to prospective study results presented at American Society for Radiation Oncology Annual Meeting.

A novel therapeutic approach could intercept rogue cancer cells before they develop into brain metastases, according to study findings.

Higher omega-3 and omega-6 fatty acid levels may help reduce cancer risk, according to study findings.

Smoking cessation within 6 months of a cancer diagnosis can significantly improve survival, according to results of a prospective study.

Lack of health insurance contributes to a high percentage of racial and ethnic disparities in advanced-stage diagnoses for several cancer types, according to results of a mediation analysis.